Blood borne Viruses Flashcards
Human Immunodeficiency virus
Enveloped with linear, dimeric, ssRNA (+) genome
Family: Retroviridae
Species: HIV 1 and 2
4 groups: M, N, O, P
M subtypes: A to K
In the Americas: group M, subtype B is dominant
3 stages of HIV disease
- Primary infection: Acute stage, 3-6 weeks, mononucleosis-like syndrome (fever, maculopapular rash, oral ulcers lymphadenopathy, malaise, weight loss, arthralgia, night sweats)
- Clinical latency: years, despite no symptoms, active replication occurs if untreated
- AIDS: opportunistic infections and/or tumors
When should you give HIV post-exposure prophylaxis
Within 2 hours of exposure is best
May not be effective after 72 hours
What type of treatment do you use for HIV?
Highly active antiretroviral therapy (HAART)
4 Lab diagnostic tests for HIV
- HIV screening assays
- Confirmatory testing
- Viral loads to monitor treatments
- Antiviral resistance testing
Why should you always use a 4th generation EIA for HIV?
It detects antibodies to HIV as well as an HIV antigen (P24 antigen)
Reduce the window period!
Hepatitis C virus
ssRNA (+), enveloped
Fam: Flaviviridae, Gen: Hepacivirus
Genotypes 1 to 6
Hep C signs and symptoms
Abdominal pain Jaundice Nausea/vomiting Swollen abdomen Itchy skin Weight loss
What enzyme is used as a marker for liver damage?
Alanine aminotransferase
Why do we need to do HCV genotyping?
Helps determine treatment and duration
Direct acting antivirals (3) for HCV
RNA Replicase inhibitors (2 types)
Protease inhibitors
NS5A inhibitors
How to monitor HCV viral loads
Real time RT-PCR performed over time reveals treatment success or failure
Hepatitis B virus
Enveloped, partially dsDNA
Encodes a reverse transcriptase (like HIV)
Fam: Hepadnaviridae, gen: orthohepadnavirus
Perinatal and horizontal transmission (child to child, contaminated needed, sexual contacts, healthcare worker, blood transfusion)
Treatment for HBV
alpha-interferon
Lamivudine
Newer agents..
5 drugs to treat HIV
- Nucleoside and non-nucleoside reverse transcriptase inhibitors (NRTIs and NNRTIs) - most common
- Fusion inhibitors
- Protease inhibitors
- Integrase inhibitors
- CCR5 co receptor antagonists